Breakthrough discoveries at PolyU offer new hope for patients
As humans continue to fight against numerous diseases, not the least of which is the latest COVID-19 pandemic, of huge concern to scientists are the health risks posed by obesity, linked to such chronic conditions as diabetes, heart disease, high blood pressure, and cancer, and the overuse of antibiotics, which can trigger antibiotic resistance and even the creation of "superbugs". There are reports of the emergence of “superbugs" which do not respond to all currently available antibiotics.
Fortunately, after years of dedicated efforts, PolyU research teams have made significant breakthroughs in addressing the above risks, through developing a new drug to cure multiple obesity-related diseases and repurposing existing drugs to fight “superbugs".
You Might Also Like
Four students awarded Innovation and Technology Scholarship
PolyU places great emphasis on nurturing students’ technology literacy and innovative mindset. By launching initiatives such as the Artificial Intelligence and Data Analytics course as an undergraduate requisite and the Undergraduate Research...
Construction of new student hostel commences to promote holistic development
To help enrich the learning experience for PolyU students and ease the shortfall of student residential places, the University will construct a new student hostel at Tat Hong Avenue in Kowloon Tong, providing 1,680 student hostel places, and both...
PolyU researchers win ZPrize for groundbreaking Web3 technology in zero-knowledge cryptography
Zero-knowledge cryptography, also known as zero-knowledge proofs (ZKPs), has emerged from academia into the business world as a solution that could address the pressing issues of data privacy and scalability limits. Led by the University’s...